Trial site
Connecticut Children's Hospital
- 10running trials
- 3closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers11 trials
- Neuroblastoma10 trials
- Sarcoma3 trials
- Asthma1 trial
- Kidney cancer1 trial
- Liver and biliary tract cancer1 trial
- Meningioma1 trial
- Phase
- Phase 27 trials
- Phase 1/23 trials
- Status
- Recruiting7 trials
- Active, not recruiting3 trials
- Completed3 trials
- Lead sponsor
- Giselle Sholler10 trials
- Milton S. Hershey Medical Center2 trials
- Boston Children's Hospital1 trial
Running trials
Recruiting
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
Recruiting
Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
Recruiting
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
Recruiting
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Recruiting
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
Recruiting
Active, not recruiting
Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
Active, not recruiting
Active, not recruiting
Recruiting
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers7 recruiting
- Neuroblastoma5 recruiting
- Sarcoma2 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026